← brief for 2026-10-07 · Slowing decline

Real-world Practice Patterns and Barriers to SGLT2 Inhibitor Use: A Nationwide Survey of Japanese General Practitioners.

Article C Peer reviewed Observational

Key takeaways

This survey looked at how doctors in Japan treat kidney disease. It found that many general practitioners are not using SGLT2 inhibitors, a type of drug that helps protect the kidneys. The study compared doctors who use the drug often with those who do not. It shows a link between doctor habits and patient care, but it is not a test of the drug itself.

Who did this work

Tatematsu S · Kobayashi K · Hatta T · Isozaki T · Nakayama Y · Imura J · Takahashi T · Kitada M · Utsunomiya Y

Source

Article · PubMed, the drug frontier · 2026 Aug 21
https://pubmed.ncbi.nlm.nih.gov/42840703/